Just posted this up in the NTI - thread thought you might be interested...
Morning all!
As the title suggests results are pending for a US clinical trial conducted by the Carrick Institute ( https://carrickinstitute.com/submit-a-case-for-publication/ ) by Frederick R Carrick himself.
The study was double blinded and it has been completed it is just waiting to be published into a medical journal before the information will be made public to the company and the world for a one of a kind groundbreaking medical device for the management of kids with autism.
The device has CE certification + it is ISO certified! http://www.mentetech.com/mente-autism/ the preliminary results several months ago where outstanding! And sent the share price soaring within the day for all you quick buck day traders! As you can see from the chart below:
In the middle of September it spiked up rapidly from 16 to a high of 37 cents. REMEMBER THESE WERE JUST THE PRELIMINARY RESULTS! But they were outstanding results with the key line from the announcement being:
"Many of the children with autism scoring in a normal range after the treatment"
The company (NTI) stated that, in a clarification announcement dated 10th of January 2018:
Based on our understanding of the nature of these trials, the Company’s expectation now is that the
results will become public within a few months of data collection being completed, which will be concurrent with publication of these results and submission to the US FDA.
Lots of evidence to prove that this technology works! We're at the pointy end here people. Currently NTI is trading at 17.5 cents per share and it has a very low market cap. IMO bags to be made. Just trying to give you all the heads up pre-launch so to speak
Remember to always do your own research and bet with your head not over it...
Cheers
Red bar
